A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough
Status:
Completed
Trial end date:
2019-02-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of three doses of orvepitant,
taken once a day, in the treatment of chronic refractory cough.